Colorectal cancer(CRC) is a malignancy of the digestive system that poses a serious threat to human life and health. Approximately 1.93 million new CRC cases were identified in 2020, including0.94 million CRC-related ...Colorectal cancer(CRC) is a malignancy of the digestive system that poses a serious threat to human life and health. Approximately 1.93 million new CRC cases were identified in 2020, including0.94 million CRC-related deaths worldwide, which accounted for 10% of the global cancer incidence and 9.4% of all cancer-related fatalities[1].展开更多
Colorectal cancer(CRC)is a common and deadly disease,with over two million new cases and one million deaths in 2020[1].Risk factors include lack of exercise,obesity,high red meat consumption,low intake of fiber,smokin...Colorectal cancer(CRC)is a common and deadly disease,with over two million new cases and one million deaths in 2020[1].Risk factors include lack of exercise,obesity,high red meat consumption,low intake of fiber,smoking,and alcohol consumption,as well as genetic factors[2,3].ELFN1-AS1,located on chromosome 7p22.3,expresses a pro-oncogenic lncRNA[4-7].Wang et al.展开更多
Colorectal cancer(CRC) is a malignant tumor of the digestive system that poses a serious threat to human health. In 2018, around 1.8 million people were newly diagnosed with CRC, and 881,000 people died from the disea...Colorectal cancer(CRC) is a malignant tumor of the digestive system that poses a serious threat to human health. In 2018, around 1.8 million people were newly diagnosed with CRC, and 881,000 people died from the disease. The identification of CRCrelated genes and genetic polymorphisms will aid in the prevention and treatment of this disease.展开更多
基金supported by the Opening Project of Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials[no.JETNM202201]。
文摘Colorectal cancer(CRC) is a malignancy of the digestive system that poses a serious threat to human life and health. Approximately 1.93 million new CRC cases were identified in 2020, including0.94 million CRC-related deaths worldwide, which accounted for 10% of the global cancer incidence and 9.4% of all cancer-related fatalities[1].
基金supported by the Opening Project of Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials[No.JETNM202201]。
文摘Colorectal cancer(CRC)is a common and deadly disease,with over two million new cases and one million deaths in 2020[1].Risk factors include lack of exercise,obesity,high red meat consumption,low intake of fiber,smoking,and alcohol consumption,as well as genetic factors[2,3].ELFN1-AS1,located on chromosome 7p22.3,expresses a pro-oncogenic lncRNA[4-7].Wang et al.
基金supported by the Opening Project of Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials [No.JETNM202201]the scientific research project of Shanghai Municipal Health Commission [No.201940389]
文摘Colorectal cancer(CRC) is a malignant tumor of the digestive system that poses a serious threat to human health. In 2018, around 1.8 million people were newly diagnosed with CRC, and 881,000 people died from the disease. The identification of CRCrelated genes and genetic polymorphisms will aid in the prevention and treatment of this disease.
